Log in to save to my catalogue

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carci...

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carci...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f07a9d97d92495a99e6cbca92498ae6

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

About this item

Full title

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

Publisher

England: BioMed Central Ltd

Journal title

BMC gastroenterology, 2017-08, Vol.17 (1), p.98-98, Article 98

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

As prognosis of patients with metastatic hepatocellular carcinoma (HCC) is mainly determined by intrahepatic HCC progression, local treatment with TACE may result in improved OS, although it is not recommended. The purpose of this study was to analyze retrospectively the efficacy of TACE and its impact on OS in patients with metastatic hepatocellul...

Alternative Titles

Full title

Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2f07a9d97d92495a99e6cbca92498ae6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f07a9d97d92495a99e6cbca92498ae6

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/s12876-017-0656-z

How to access this item